Patents by Inventor Daniel Lewis Levey

Daniel Lewis Levey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200237885
    Abstract: Provided are compositions useful as therapeutic vaccines (e.g., cancer vaccines), and methods of producing such compositions. The compositions disclosed herein generally employ a stress protein and at least one synthetic peptide, which may be a phosphopeptide or phosphopeptide mimetic, comprising a cancer-specific mutation present in a patient's cancer.
    Type: Application
    Filed: January 9, 2020
    Publication date: July 30, 2020
    Inventors: Daniel Lewis Levey, John Christopher Castle, Robert Benjamin Stein, Jennifer Shanda Buell
  • Patent number: 10568948
    Abstract: Provided are compositions useful as therapeutic vaccines (e.g., cancer vaccines), and methods of producing such compositions. The compositions disclosed herein generally employ a stress protein and at least one synthetic peptide, which may be a phosphopeptide or phosphopeptide mimetic, comprising a cancer-specific mutation present in a patient's cancer.
    Type: Grant
    Filed: May 13, 2016
    Date of Patent: February 25, 2020
    Assignee: AGENUS INC.
    Inventors: Daniel Lewis Levey, John Christopher Castle
  • Publication number: 20160331821
    Abstract: Provided are compositions useful as therapeutic vaccines (e.g., cancer vaccines), and methods of producing such compositions. The compositions disclosed herein generally employ a stress protein and at least one synthetic peptide, which may be a phosphopeptide or phosphopeptide mimetic, comprising a cancer-specific mutation present in a patient's cancer.
    Type: Application
    Filed: May 13, 2016
    Publication date: November 17, 2016
    Inventors: Daniel Lewis Levey, John Christopher Castle, Robert Benjamin Stein, Jennifer Shanda Buell